PTC Therapeutics, Inc. (PTCT) stock
PTCTNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 29, 2026Score 5/3031% above fair value
$63.49+0.13 (+0.21%)
Close on Nov 13, 2026Market cap $5.30BP/E –Yield –
PTC Therapeutics statistics
75 measures from SEC filings and the closing price. Hover a name for the formula; the last column is the median of companies in the same industry group.
Important dates
- Next earnings
- –
- Last ex-dividend date
- No dividends
- Fundamentals through
- Sep 30, 2026
- Share price as of
- –
Share statisticsIndustry
- Shares Change (YoY)
- 6.59%
- 10.8%
- Shares Change (QoQ)
- 0.25%
- 0.50%
- Float
- 81M
- 49M
- Shares Held by Insiders
- 3.04%
- 11.7%
- Shares Held by Institutions
- 120.1%
- 56.4%
Short sellingIndustry
- Short Interest
- 8M
- –
- Short Interest Change
- -6.31%
- -0.80%
- Short % of Float
- 9.60%
- 9.01%
- Short % of Shares Outstanding
- 9.31%
- 6.30%
- Days to Cover
- 7.50
- 5.15
Stock price statisticsIndustry
- 52-Week High
- $90.87
- –
- 52-Week Low
- $58.80
- –
- 20-Day Moving Average
- $63.57
- –
- 50-Day Moving Average
- $64.12
- –
- 200-Day Moving Average
- $70.16
- –
- Average True Range (14)
- $2.49
- –
- Price Change (1 Week)
- -2.98%
- -1.15%
- Price Change (1 Month)
- 4.10%
- -4.87%
- Price Change (3 Months)
- -12.9%
- -21.0%
- Price Change (6 Months)
- -11.2%
- -20.6%
- Price Change (YTD)
- -16.4%
- -23.6%
- Price Change (1 Year)
- -15.3%
- -22.4%
- Price Change (3 Years)
- 212.3%
- -29.5%
- Price Change (5 Years)
- 60.7%
- -77.9%
- Price Change (10 Years)
- 426.9%
- -65.4%
- Average Volume (10 Days)
- 1M
- –
- Average Volume (20 Days)
- 1M
- –
- Average Volume (90 Days)
- 1M
- –
- Relative Volume
- 0.44
- 0.70
- Relative Strength Index (14)
- 48.6
- 43.4
- Volatility (1 Year)
- 42.9%
- 80.1%
- Beta (5 Years)
- 1.09
- 1.07
MarginsIndustry
- Pretax Margin
- -7.36%
- -11.6%
- EBITDA Margin
- 18.1%
- -27.7%
- FCF Margin
- 0.18%
- -9.56%
Returns on capitalIndustry
- Return on Assets (ROA)
- -3.62%
- -40.6%
- Return on Capital Employed (ROCE)
- 6.07%
- -37.9%
Financial positionIndustry
- Current Ratio
- 3.27
- 3.30
- Quick Ratio
- 3.05
- 2.39
- Debt / EBITDA
- 2.57
- 3.15
- Debt / FCF
- 259.44
- 4.65
- Net Debt / EBITDA
- -7.63
- 1.97
GrowthIndustry
- Revenue Growth (YoY)
- -35.1%
- 6.82%
- Net Income Growth (YoY)
- -114.1%
- -14.4%
- EPS Growth (YoY)
- -113.9%
- -12.3%
- FCF Growth (YoY)
- -99.7%
- 6.85%
- Revenue Growth (3Y CAGR)
- 35.3%
- 2.25%
- Revenue Growth (5Y CAGR)
- 35.4%
- 6.41%
EfficiencyIndustry
- Asset Turnover
- 0.39
- 0.40
- Revenue Per Employee
- $1.17M
- $429.29K
- Profits Per Employee
- -$106.93K
- -$689.41K
- Employee Count
- 991
- 74
Income statement (TTM)Industry
- Pretax Income
- -$85.09M
- -$12.95M
Balance sheetIndustry
- Net Cash (Debt)
- $1.59B
- $17.76M
- Net Cash Per Share
- $19.05
- $0.80
- Equity (Book Value)
- -$191.21M
- $53.89M
- Book Value Per Share
- -$2.29
- $1.50
- Tangible Book Value
- -$717.24M
- $27.13M
- Working Capital
- $1.76B
- $79.99M
Cash flow (TTM)Industry
- Capital Expenditures
- -$8.42M
- -$1.00M
- FCF Per Share
- $0.02
- -$0.42
Taxes and interestIndustry
- Income Tax
- $20.88M
- $73.00K
Scores and fair valueIndustry
- Piotroski F-Score
- 5
- 4
Total return vs. the S&P 500
Price change plus reinvested dividends, to the close on Nov 13, 2026. The S&P 500 is measured by the SPY fund.
| Period | PTCT | S&P 500 | Difference | PTCT per year | S&P 500 per year |
|---|---|---|---|---|---|
| 1 month | +6.0% | -3.0% | +9.0 pts | ||
| 3 months | -11.8% | -2.8% | −9.0 pts | ||
| Year to date | -16.4% | +11.5% | −27.9 pts | ||
| 1 year | -15.3% | +13.5% | −28.8 pts | ||
| 3 years | +242.6% | +77.7% | +164.9 pts | +50.8% | +21.1% |
| 5 years | +60.7% | +72.6% | −11.9 pts | +10.0% | +11.5% |
| 10 years | +461.9% | +308.2% | +153.7 pts | +18.8% | +15.1% |
Short interest
Shares sold short and not yet covered, reported by brokers to FINRA twice a month. Latest settlement date Oct 30, 2026.
8M PTCT shares were sold short on Oct 30, 2026, down 6.3% from the previous report, or 9.60% of the shares available to trade. At recent volumes it would take 7.5 days to buy them back. Over the last 20 sessions, 45.6% of the volume reported to FINRA was short selling.
| Settlement date | Shares short | Change | Avg. daily volume | Days to cover |
|---|---|---|---|---|
| Oct 30, 2026 | 7,779,250 | -6.3% | 1,037,445 | 7.5 |
| Oct 15, 2026 | 8,303,282 | -9.4% | 1,094,576 | 7.6 |
| Sep 30, 2026 | 9,168,333 | -5.9% | 1,493,955 | 6.1 |
| Sep 15, 2026 | 9,738,919 | -0.9% | 882,762 | 11.0 |
| Aug 31, 2026 | 9,828,154 | -3.8% | 809,909 | 12.1 |
| Aug 14, 2026 | 10,221,046 | -3.3% | 944,361 | 10.8 |
| Jul 31, 2026 | 10,566,249 | +7.4% | 1,404,384 | 7.5 |
| Jul 15, 2026 | 9,833,980 | -43.2% | 2,069,373 | 4.8 |
| Jun 30, 2026 | 17,315,032 | +46.9% | 3,228,848 | 5.4 |
| Jun 15, 2026 | 11,783,786 | +10.4% | 1,505,935 | 7.8 |
| May 29, 2026 | 10,674,185 | +4.2% | 963,231 | 11.1 |
| May 15, 2026 | 10,240,784 | +5.0% | 1,708,791 | 6.0 |
Ratios use trailing-twelve-month results and the latest balance sheet. How we calculate.
See a number that looks wrong?